OncoCyte Total Current Assets 2014-2024 | OCX
OncoCyte Annual Total Current Assets (Millions of US $) |
|
---|---|
2023 | $11 |
2022 | $26 |
2021 | $39 |
2020 | $9 |
2019 | $23 |
2018 | $9 |
2017 | $9 |
2016 | $13 |
2015 | $11 |
2014 | $4 |
2013 | $5 |
OncoCyte Quarterly Total Current Assets (Millions of US $) |
|
---|---|
2024-09-30 | $5 |
2024-06-30 | $10 |
2024-03-31 | $7 |
2023-12-31 | $11 |
2023-09-30 | $17 |
2023-06-30 | $21 |
2023-03-31 | $16 |
2022-12-31 | $26 |
2022-09-30 | $37 |
2022-06-30 | $49 |
2022-03-31 | $25 |
2021-12-31 | $39 |
2021-09-30 | $48 |
2021-06-30 | $50 |
2021-03-31 | $63 |
2020-12-31 | $9 |
2020-09-30 | $12 |
2020-06-30 | $18 |
2020-03-31 | $18 |
2019-12-31 | $23 |
2019-09-30 | $20 |
2019-06-30 | $37 |
2019-03-31 | $41 |
2018-12-31 | $9 |
2018-09-30 | $12 |
2018-06-30 | $11 |
2018-03-31 | $14 |
2017-12-31 | $9 |
2017-09-30 | $12 |
2017-06-30 | $10 |
2017-03-31 | $13 |
2016-12-31 | $13 |
2016-09-30 | $15 |
2016-06-30 | $6 |
2016-03-31 | $8 |
2015-12-31 | $11 |
2015-09-30 | |
2015-06-30 | |
2015-03-31 | |
2014-12-31 | $4 |
2013-12-31 | $5 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.045B | $0.002B |
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $93.604B | 11.61 |
Cencora (COR) | United States | $48.412B | 17.85 |
DiDi Global (DIDIY) | China | $22.941B | 0.00 |
Natera (NTRA) | United States | $22.359B | 0.00 |
ICON (ICLR) | Ireland | $17.552B | 15.63 |
Viatris (VTRS) | United States | $15.815B | 4.87 |
Avantor (AVTR) | United States | $13.857B | 20.78 |
Revvity (RVTY) | United States | $13.522B | 23.49 |
CochLear (CHEOY) | Australia | $12.586B | 0.00 |
BioMerieux (BMXMF) | France | $12.119B | 0.00 |
Solventum (SOLV) | United States | $12.029B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.624B | 29.93 |
Charles River Laboratories (CRL) | United States | $9.930B | 19.19 |
HealthEquity (HQY) | United States | $9.139B | 49.60 |
Doximity (DOCS) | United States | $8.961B | 52.75 |
Sonic Healthcare (SKHHY) | Australia | $8.813B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.977B | 32.47 |
Life Times (LTH) | United States | $5.046B | 33.40 |
Organon (OGN) | United States | $3.835B | 3.87 |
Sotera Health (SHC) | United States | $3.515B | 18.80 |
BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
Surgery Partners (SGRY) | United States | $2.968B | 33.84 |
Concentras Parent (CON) | United States | $2.735B | 0.00 |
PACS (PACS) | United States | $2.522B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.320B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.255B | 0.00 |
Premier (PINC) | United States | $2.155B | 11.21 |
Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
GeneDx Holdings (WGS) | United States | $1.980B | 0.00 |
Teladoc Health (TDOC) | United States | $1.791B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.635B | 42.90 |
Progyny (PGNY) | United States | $1.275B | 25.81 |
Pediatrix Medical (MD) | United States | $1.267B | 12.40 |
CareDx (CDNA) | United States | $1.211B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.193B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.978B | 6.62 |
Embecta (EMBC) | United States | $0.808B | 5.38 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.733B | 0.00 |
SBC Medicals (SBC) | United States | $0.670B | 0.00 |
InnovAge Holding (INNV) | United States | $0.627B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.526B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
DocGo (DCGO) | United States | $0.420B | 15.85 |
Enhabit (EHAB) | United States | $0.376B | 32.48 |
COMPASS Pathways (CMPS) | United Kingdom | $0.304B | 0.00 |
ModivCare (MODV) | United States | $0.250B | 13.54 |
LifeMD (LFMD) | United States | $0.246B | 0.00 |
Sera Prognostics (SERA) | United States | $0.206B | 0.00 |
Biodesix (BDSX) | United States | $0.175B | 0.00 |
Nutex Health (NUTX) | United States | $0.173B | 0.00 |
Beauty Health (SKIN) | United States | $0.173B | 0.00 |
MultiPlan (MPLN) | United States | $0.114B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.094B | 0.00 |
So-Young (SY) | China | $0.093B | 17.98 |
Singular Genomics Systems (OMIC) | United States | $0.055B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.11 |
Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.022B | 0.00 |
Oncology Institute (TOI) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
KindlyMD (KDLY) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |